<billStatus>
 <version>
  3.0.0
 </version>
 <bill>
  <number>
   728
  </number>
  <updateDate>
   2023-01-11T13:46:57Z
  </updateDate>
  <updateDateIncludingText>
   2023-01-11T13:46:57Z
  </updateDateIncludingText>
  <originChamber>
   House
  </originChamber>
  <type>
   HR
  </type>
  <introducedDate>
   2021-02-02
  </introducedDate>
  <congress>
   117
  </congress>
  <constitutionalAuthorityStatementText>
   &lt;pre&gt;[Congressional Record Volume 167, Number 19 (Tuesday, February 2, 2021)][House]From the Congressional Record Online through the Government Publishing Office [&lt;a href="https://www.gpo.gov"&gt;www.gpo.gov&lt;/a&gt;]By Ms. SCHAKOWSKY:H.R. 728.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8, Clause 3The Congress shall have Power . . . To regulate Commercewith foreign Nations, and among the several States, and withthe Indian Tribes.[Page H280]&lt;/pre&gt;
  </constitutionalAuthorityStatementText>
  <committees>
   <item>
    <systemCode>
     hsif00
    </systemCode>
    <name>
     Energy and Commerce Committee
    </name>
    <chamber>
     House
    </chamber>
    <type>
     Standing
    </type>
    <subcommittees>
     <item>
      <systemCode>
       hsif14
      </systemCode>
      <name>
       Health Subcommittee
      </name>
      <activities>
       <item>
        <name>
         Referred to
        </name>
        <date>
         2021-02-03T19:28:23Z
        </date>
       </item>
      </activities>
     </item>
    </subcommittees>
    <activities>
     <item>
      <name>
       Referred to
      </name>
      <date>
       2021-02-02T19:05:05Z
      </date>
     </item>
    </activities>
   </item>
  </committees>
  <relatedBills>
   <item>
    <title>
     Pandemic Emergency Manufacturing Act of 2021
    </title>
    <congress>
     117
    </congress>
    <number>
     187
    </number>
    <type>
     S
    </type>
    <latestAction>
     <actionDate>
      2021-02-03
     </actionDate>
     <text>
      Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
     </text>
    </latestAction>
    <relationshipDetails>
     <item>
      <type>
       Related bill
      </type>
      <identifiedBy>
       CRS
      </identifiedBy>
     </item>
    </relationshipDetails>
   </item>
  </relatedBills>
  <actions>
   <item>
    <actionDate>
     2021-02-03
    </actionDate>
    <committees>
     <item>
      <systemCode>
       hsif14
      </systemCode>
      <name>
       Health Subcommittee
      </name>
     </item>
    </committees>
    <sourceSystem>
     <code>
      1
     </code>
     <name>
      House committee actions
     </name>
    </sourceSystem>
    <text>
     Referred to the Subcommittee on Health.
    </text>
    <type>
     Committee
    </type>
   </item>
   <item>
    <actionDate>
     2021-02-02
    </actionDate>
    <text>
     Referred to the House Committee on Energy and Commerce.
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     H11100
    </actionCode>
    <sourceSystem>
     <code>
      2
     </code>
     <name>
      House floor actions
     </name>
    </sourceSystem>
    <committees>
     <item>
      <systemCode>
       hsif00
      </systemCode>
      <name>
       Energy and Commerce Committee
      </name>
     </item>
    </committees>
   </item>
   <item>
    <actionDate>
     2021-02-02
    </actionDate>
    <text>
     Introduced in House
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     Intro-H
    </actionCode>
    <sourceSystem>
     <code>
      9
     </code>
     <name>
      Library of Congress
     </name>
    </sourceSystem>
   </item>
   <item>
    <actionDate>
     2021-02-02
    </actionDate>
    <text>
     Introduced in House
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     1000
    </actionCode>
    <sourceSystem>
     <code>
      9
     </code>
     <name>
      Library of Congress
     </name>
    </sourceSystem>
   </item>
  </actions>
  <sponsors>
   <item>
    <bioguideId>
     S001145
    </bioguideId>
    <fullName>
     Rep. Schakowsky, Janice D. [D-IL-9]
    </fullName>
    <firstName>
     JANICE
    </firstName>
    <lastName>
     SCHAKOWSKY
    </lastName>
    <party>
     D
    </party>
    <state>
     IL
    </state>
    <middleName>
     D.
    </middleName>
    <district>
     9
    </district>
    <isByRequest>
     N
    </isByRequest>
   </item>
  </sponsors>
  <cosponsors>
   <item>
    <bioguideId>
     J000032
    </bioguideId>
    <fullName>
     Rep. Jackson Lee, Sheila [D-TX-18]
    </fullName>
    <firstName>
     SHEILA
    </firstName>
    <lastName>
     JACKSON LEE
    </lastName>
    <party>
     D
    </party>
    <state>
     TX
    </state>
    <district>
     18
    </district>
    <sponsorshipDate>
     2021-02-22
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
  </cosponsors>
  <policyArea>
   <name>
    Health
   </name>
  </policyArea>
  <subjects>
   <legislativeSubjects>
    <item>
     <name>
      Blood and blood diseases
     </name>
    </item>
    <item>
     <name>
      Cardiovascular and respiratory health
     </name>
    </item>
    <item>
     <name>
      Congressional oversight
     </name>
    </item>
    <item>
     <name>
      Corporate finance and management
     </name>
    </item>
    <item>
     <name>
      Department of Health and Human Services
     </name>
    </item>
    <item>
     <name>
      Drug safety, medical device, and laboratory regulation
     </name>
    </item>
    <item>
     <name>
      Emergency medical services and trauma care
     </name>
    </item>
    <item>
     <name>
      Executive agency funding and structure
     </name>
    </item>
    <item>
     <name>
      Federal officials
     </name>
    </item>
    <item>
     <name>
      Genetics
     </name>
    </item>
    <item>
     <name>
      Government ethics and transparency, public corruption
     </name>
    </item>
    <item>
     <name>
      Government information and archives
     </name>
    </item>
    <item>
     <name>
      Government studies and investigations
     </name>
    </item>
    <item>
     <name>
      Health personnel
     </name>
    </item>
    <item>
     <name>
      Health technology, devices, supplies
     </name>
    </item>
    <item>
     <name>
      Immunology and vaccination
     </name>
    </item>
    <item>
     <name>
      Indian social and development programs
     </name>
    </item>
    <item>
     <name>
      Infectious and parasitic diseases
     </name>
    </item>
    <item>
     <name>
      Inflation and prices
     </name>
    </item>
    <item>
     <name>
      Licensing and registrations
     </name>
    </item>
    <item>
     <name>
      Manufacturing
     </name>
    </item>
    <item>
     <name>
      Marketing and advertising
     </name>
    </item>
    <item>
     <name>
      Medical tests and diagnostic methods
     </name>
    </item>
    <item>
     <name>
      Minority health
     </name>
    </item>
    <item>
     <name>
      Prescription drugs
     </name>
    </item>
    <item>
     <name>
      Public contracts and procurement
     </name>
    </item>
    <item>
     <name>
      Public participation and lobbying
     </name>
    </item>
    <item>
     <name>
      State and local government operations
     </name>
    </item>
    <item>
     <name>
      Strategic materials and reserves
     </name>
    </item>
    <item>
     <name>
      Worker safety and health
     </name>
    </item>
   </legislativeSubjects>
   <policyArea>
    <name>
     Health
    </name>
   </policyArea>
  </subjects>
  <summaries>
   <summary>
    <versionCode>
     00
    </versionCode>
    <actionDate>
     2021-02-02
    </actionDate>
    <actionDesc>
     Introduced in House
    </actionDesc>
    <updateDate>
     2021-03-18T18:20:41Z
    </updateDate>
    <text>
     &lt;p&gt;&lt;b&gt;Pandemic Emergency Manufacturing Act of 2021&lt;/b&gt;&lt;/p&gt; &lt;p&gt;This bill establishes within the Department of Health and Human Services (HHS) an Emergency Office of Manufacturing for Public Health to manufacture and distribute medical products to address COVID-19 (i.e., coronavirus disease 2019) or medical products that are on shortage or vulnerable to shortage.&lt;/p&gt; &lt;p&gt;The office must (1) obtain the rights to manufacture the applicable medicines, ingredients, diagnostic tests, medical devices, personal protective equipment, and supplies; (2) manufacture or contract to manufacture such items; and (3) construct, or enter into construction contracts for, facilities to manufacture certain medicines, such as vaccines.&lt;/p&gt; &lt;p&gt;HHS may issue involuntary licenses allowing the office to make, use, sell, import, or export an invention related to an applicable drug, biological product, or device and to use clinical trial data and confidential information. Such a license must provide the rights holder with reasonable compensation.&lt;/p&gt; &lt;p&gt;The office must (1) provide such COVID-19 products at no cost to federal, state, local, and other health programs and certain domestic health care providers and suppliers; (2) offer COVID-19 products at cost to other commercial and international entities; and (3) offer other medical products to entities at a fair price, based on cost and other considerations. &lt;/p&gt; &lt;p&gt;The office shall prioritize the manufacture of certain COVID-19 products and meet manufacturing timelines specified in the bill.&lt;/p&gt;
    </text>
   </summary>
  </summaries>
  <title>
   Pandemic Emergency Manufacturing Act of 2021
  </title>
  <titles>
   <item>
    <titleType>
     Display Title
    </titleType>
    <title>
     Pandemic Emergency Manufacturing Act of 2021
    </title>
   </item>
   <item>
    <titleType>
     Official Title as Introduced
    </titleType>
    <title>
     To amend the Public Health Service Act to establish an Emergency Office of Manufacturing for Public Health, and for other purposes.
    </title>
    <billTextVersionName>
     Introduced in House
    </billTextVersionName>
    <billTextVersionCode>
     IH
    </billTextVersionCode>
   </item>
   <item>
    <titleType>
     Short Title(s) as Introduced
    </titleType>
    <title>
     Pandemic Emergency Manufacturing Act of 2021
    </title>
    <billTextVersionName>
     Introduced in House
    </billTextVersionName>
    <billTextVersionCode>
     IH
    </billTextVersionCode>
   </item>
  </titles>
  <textVersions>
   <item>
    <type>
     Introduced in House
    </type>
    <date>
     2021-02-02T05:00:00Z
    </date>
    <formats>
     <item>
      <url>
       https://www.govinfo.gov/content/pkg/BILLS-117hr728ih/xml/BILLS-117hr728ih.xml
      </url>
     </item>
    </formats>
   </item>
  </textVersions>
  <latestAction>
   <actionDate>
    2021-02-03
   </actionDate>
   <text>
    Referred to the Subcommittee on Health.
   </text>
  </latestAction>
 </bill>
 <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
  <dc:format>
   text/xml
  </dc:format>
  <dc:language>
   EN
  </dc:language>
  <dc:rights>
   Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
  </dc:rights>
  <dc:contributor>
   Congressional Research Service, Library of Congress
  </dc:contributor>
  <dc:description>
   This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.
  </dc:description>
 </dublinCore>
</billStatus>

2021-02-03
Health Subcommittee
hsif14
1
House committee actions
Referred to the Subcommittee on Health.
Committee
H11100
2021-02-02
Energy and Commerce Committee
hsif00
2
House floor actions
Referred to the House Committee on Energy and Commerce.
IntroReferral
Intro-H
2021-02-02
9
Library of Congress
Introduced in House
IntroReferral
1000
2021-02-02
9
Library of Congress
Introduced in House
IntroReferral
2021-02-02T19:05:05Z
Referred to
House
Energy and Commerce Committee
2021-02-03T19:28:23Z
Referred to
Health Subcommittee
hsif14
hsif00
Standing
J000032
18
SHEILA
Rep. Jackson Lee, Sheila [D-TX-18]
JACKSON LEE
D
2021-02-22
TX
Congressional Research Service, Library of Congress
This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
2021-02-02
2021-02-03
Referred to the Subcommittee on Health.
House
Health
2021-02-03
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
CRS
Related bill
Pandemic Emergency Manufacturing Act of 2021
S
S001145
9
JANICE
Rep. Schakowsky, Janice D. [D-IL-9]
N
SCHAKOWSKY
D.
D
IL
Blood and blood diseases Cardiovascular and respiratory health Congressional oversight Corporate finance and management Department of Health and Human Services Drug safety, medical device, and laboratory regulation Emergency medical services and trauma care Executive agency funding and structure Federal officials Genetics Government ethics and transparency, public corruption Government information and archives Government studies and investigations Health personnel Health technology, devices, supplies Immunology and vaccination Indian social and development programs Infectious and parasitic diseases Inflation and prices Licensing and registrations Manufacturing Marketing and advertising Medical tests and diagnostic methods Minority health Prescription drugs Public contracts and procurement Public participation and lobbying State and local government operations Strategic materials and reserves Worker safety and health
2021-02-02
Introduced in House
 <p><b>Pandemic Emergency Manufacturing Act of 2021</b></p> <p>This bill establishes within the Department of Health and Human Services (HHS) an Emergency Office of Manufacturing for Public Health to manufacture and distribute medical products to address COVID-19 (i.e., coronavirus disease 2019) or medical products that are on shortage or vulnerable to shortage.</p> <p>The office must (1) obtain the rights to manufacture the applicable medicines, ingredients, diagnostic tests, medical devices, personal protective equipment, and supplies; (2) manufacture or contract to manufacture such items; and (3) construct, or enter into construction contracts for, facilities to manufacture certain medicines, such as vaccines.</p> <p>HHS may issue involuntary licenses allowing the office to make, use, sell, import, or export an invention related to an applicable drug, biological product, or device and to use clinical trial data and confidential information. Such a license must provide the rights holder with reasonable compensation.</p> <p>The office must (1) provide such COVID-19 products at no cost to federal, state, local, and other health programs and certain domestic health care providers and suppliers; (2) offer COVID-19 products at cost to other commercial and international entities; and (3) offer other medical products to entities at a fair price, based on cost and other considerations. </p> <p>The office shall prioritize the manufacture of certain COVID-19 products and meet manufacturing timelines specified in the bill.</p>
2021-03-18T18:20:41Z
00
2021-02-02T05:00:00Z
Introduced in House
https://www.govinfo.gov/content/pkg/BILLS-117hr728ih/xml/BILLS-117hr728ih.xml
Pandemic Emergency Manufacturing Act of 2021
Pandemic Emergency Manufacturing Act of 2021
Display Title
IH
Introduced in House
To amend the Public Health Service Act to establish an Emergency Office of Manufacturing for Public Health, and for other purposes.
Official Title as Introduced
IH
Introduced in House
Pandemic Emergency Manufacturing Act of 2021
Short Title(s) as Introduced
HR
2023-01-11T13:46:57Z
2023-01-11T13:46:57Z
3.0.0
2021-02-03
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
CRS
Related bill
Pandemic Emergency Manufacturing Act of 2021
S
2021-02-03
Health Subcommittee
hsif14
1
House committee actions
Referred to the Subcommittee on Health.
Committee
H11100
2021-02-02
Energy and Commerce Committee
hsif00
2
House floor actions
Referred to the House Committee on Energy and Commerce.
IntroReferral
Intro-H
2021-02-02
9
Library of Congress
Introduced in House
IntroReferral
1000
2021-02-02
9
Library of Congress
Introduced in House
IntroReferral
S001145
9
JANICE
Rep. Schakowsky, Janice D. [D-IL-9]
N
SCHAKOWSKY
D.
D
IL
J000032
18
SHEILA
Rep. Jackson Lee, Sheila [D-TX-18]
JACKSON LEE
D
2021-02-22
TX
Blood and blood diseases Cardiovascular and respiratory health Congressional oversight Corporate finance and management Department of Health and Human Services Drug safety, medical device, and laboratory regulation Emergency medical services and trauma care Executive agency funding and structure Federal officials Genetics Government ethics and transparency, public corruption Government information and archives Government studies and investigations Health personnel Health technology, devices, supplies Immunology and vaccination Indian social and development programs Infectious and parasitic diseases Inflation and prices Licensing and registrations Manufacturing Marketing and advertising Medical tests and diagnostic methods Minority health Prescription drugs Public contracts and procurement Public participation and lobbying State and local government operations Strategic materials and reserves Worker safety and health
2021-02-02
Introduced in House
 <p><b>Pandemic Emergency Manufacturing Act of 2021</b></p> <p>This bill establishes within the Department of Health and Human Services (HHS) an Emergency Office of Manufacturing for Public Health to manufacture and distribute medical products to address COVID-19 (i.e., coronavirus disease 2019) or medical products that are on shortage or vulnerable to shortage.</p> <p>The office must (1) obtain the rights to manufacture the applicable medicines, ingredients, diagnostic tests, medical devices, personal protective equipment, and supplies; (2) manufacture or contract to manufacture such items; and (3) construct, or enter into construction contracts for, facilities to manufacture certain medicines, such as vaccines.</p> <p>HHS may issue involuntary licenses allowing the office to make, use, sell, import, or export an invention related to an applicable drug, biological product, or device and to use clinical trial data and confidential information. Such a license must provide the rights holder with reasonable compensation.</p> <p>The office must (1) provide such COVID-19 products at no cost to federal, state, local, and other health programs and certain domestic health care providers and suppliers; (2) offer COVID-19 products at cost to other commercial and international entities; and (3) offer other medical products to entities at a fair price, based on cost and other considerations. </p> <p>The office shall prioritize the manufacture of certain COVID-19 products and meet manufacturing timelines specified in the bill.</p>
2021-03-18T18:20:41Z
00
Pandemic Emergency Manufacturing Act of 2021
Pandemic Emergency Manufacturing Act of 2021
Display Title
IH
Introduced in House
To amend the Public Health Service Act to establish an Emergency Office of Manufacturing for Public Health, and for other purposes.
Official Title as Introduced
IH
Introduced in House
Pandemic Emergency Manufacturing Act of 2021
Short Title(s) as Introduced
2021-02-03
Referred to the Subcommittee on Health.